These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16078932)

  • 1. Earlier detection of HLA alloimmunization in platelet transfusion refractoriness by flow cytometric analysis.
    Sato S; Sakurai T; Yamamoto Y; Maekawa I; Ikeda H
    Transfusion; 2005 Aug; 45(8):1399-401. PubMed ID: 16078932
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness.
    Beligaswatte A; Tsiopelas E; Humphreys I; Bennett G; Robinson K; Davis K; Bardy P
    Br J Haematol; 2013 Aug; 162(3):409-12. PubMed ID: 23651440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and causes of refractoriness in multiply transfused patients.
    Legler TJ; Fischer I; Dittmann J; Simson G; Lynen R; Humpe A; Riggert J; Schleyer E; Kern W; Hiddemann W; Köhler M
    Ann Hematol; 1997 Apr; 74(4):185-9. PubMed ID: 9174547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
    Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
    Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red-blood-cell alloimmunization and female sex predict the presence of HLA antibodies in patients undergoing liver transplant.
    Sanz C; Ghita G; Franquet C; Martínez I; Pereira A
    Vox Sang; 2010 Oct; 99(3):261-6. PubMed ID: 20840340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
    Arber C; Bertrand G; Halter J; Boehlen F; Kaplan C; Gratwohl A
    Br J Haematol; 2007 Oct; 139(1):159-61. PubMed ID: 17854320
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for the selection of platelet products for alloimmune-refractory patients.
    Kopko PM; Warner P; Kresie L; Pancoska C
    Transfusion; 2015 Feb; 55(2):235-44. PubMed ID: 25393955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of HLA alloimmunization due to platelet transfusion].
    van Marwijk Kooy M; Brand A; Sintnicolaas K; van Prooijen HC
    Ned Tijdschr Geneeskd; 1988 Apr; 132(17):758-61. PubMed ID: 3374659
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions.
    Vamvakas EC
    Transfus Med Rev; 1998 Oct; 12(4):258-70. PubMed ID: 9798269
    [No Abstract]   [Full Text] [Related]  

  • 14. The repercussions of implementing flow cytometry as a single HLA antibody screening technique in prospective renal transplant recipients.
    Magee B; Martin J; Middleton D
    Transpl Int; 2006 Feb; 19(2):105-9. PubMed ID: 16441358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and sensitivity of screening for anti-HLA antibodies in kidney allograft dysfunction.
    Viana H; Nolasco F; Santos MC; Carvalho F; Galvão MJ; Santos AR; Bordalo J; Dos Santos JR
    Transplant Proc; 2009 Apr; 41(3):859-61. PubMed ID: 19376372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for managing refractoriness to platelet transfusions.
    Dan ME; Schiffer CA
    Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies.
    Fujiwara K; Shimano K; Tanaka H; Sekine M; Kashiwase K; Uchikawa M; Satake M; Nakajima K
    Vox Sang; 2009 Apr; 96(3):244-51. PubMed ID: 19207165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation.
    Schumm M; Feuchtinger T; Pfeiffer M; Hoelle W; Bethge W; Ebinger M; Kuci S; Handgretinger R; Lang P
    Bone Marrow Transplant; 2007 Jun; 39(12):767-73. PubMed ID: 17438586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion refractoriness--prevention and therapeutical approaches.
    Novotny VM
    Transfus Clin Biol; 1995; 2(1):47-9. PubMed ID: 7728268
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies.
    Masson E; Stern M; Chabod J; Thévenin C; Gonin F; Rebibou JM; Tiberghien P
    J Heart Lung Transplant; 2007 Jun; 26(6):642-5. PubMed ID: 17543791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.